封面
市場調查報告書
商品編碼
1566942

仿生智慧膝關節市場:依材料、最終用戶分類:2024-2033 年全球機會分析與產業預測

Bionic Smart Knee Market By Material (Titanium, Graphite) , By End User (Hospitals, Orthopedic Clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

仿生智慧膝關節市場

2023年仿生智慧膝關節市場價值為13億美元,預計2024年至2033年複合年成長率為7.8%,到2033年將達到28億美元。

仿生智慧膝關節是膝關節關節重建手術的獨特膝關節假體。該設備配備了感測器、微處理器和藍牙技術,以方便全膝關節關節重建手術。這種智慧膝蓋模仿人類膝蓋的自然功能,同時提高舒適度和靈活性。仿生智慧膝關節的主要特點包括動態可調節性和出色的步態分析。此外,該設備的連接功能允許與外部設備和行動應用程式整合,從而允許用戶監控效能並自訂設定和效能。

技術和材料科學的進步正在推動仿生智慧膝蓋市場的成長,因為這些升級的設備為使用者提供了複雜的功能和體驗。此外,人們對運動障礙和膝關節損傷盛行率上升的認知不斷提高,以及先進療法的可用性正在推動仿生智慧膝蓋的採用。仿生智慧膝蓋市場的新興趨勢是設備的神經人工控制。透過神經功能控制智慧膝蓋有望增強該裝置對人類自然步態的模仿能力。為了促進神經控制,對膝關節運動重要的主動肌和拮抗肌對必須透過手術連接以模仿自然動力學。

然而,成功進行膝關節關節重建手術的義肢和矯正器具主要局限於已開發地區,阻礙了市場的成長。此外,智慧膝關節管理、維護和保險費用高昂,阻礙了精打細算的患者進行膝關節關節重建手術,限制了市場的廣泛擴張。根據美國新聞雜誌《美國新聞與世界報道》報導,機器人智慧膝關節關節重建比傳統置換術平均成本高出約2,400美元。相反,隨著遠端醫療的出現,這個市場將迎來利潤豐厚的機會。仿生智慧膝關節可實現遠距醫療檢查和術後監測,無需術後多次前往醫院。

按部門審查

仿生智慧膝蓋市場分為材料、最終用戶和地區。依材質,市場分為鈦和石墨。依最終使用者分為醫院、整形外科診所等。從區域來看,我們對北美、歐洲、亞太地區和拉丁美洲地區進行了分析。

主要發現

從材料來看,鈦金屬在仿生智慧膝關節市場佔據主導地位。

從最終用戶來看,醫院引領市場。

按地區分類,北美地區 2023 年收益最高。

可以使用此報告進行客製化(需要額外費用和時間表)

  • 根據客戶興趣加入公司簡介
  • 公司簡介的擴充列表

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章仿生智慧膝關節市場:依材料分類

  • 市場概況
  • 石墨

第5章仿生智慧膝關節市場:依最終用戶分類

  • 市場概況
  • 醫院
  • 整形外科診所
  • 其他

第6章仿生智慧膝關節市場:依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國仿生智慧膝關節市場
    • 加拿大仿生智慧膝關節市場
    • 墨西哥仿生智慧膝蓋市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國仿生智慧膝關節市場
    • 德國仿生智慧膝關節市場
    • 義大利仿生智慧膝關節市場
    • 西班牙仿生智慧膝關節市場
    • 英國仿生智慧膝關節市場
    • 其他歐洲國家仿生智慧膝蓋市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國仿生智慧膝關節市場
    • 日本仿生智慧膝關節市場
    • 印度仿生智慧膝關節市場
    • 韓國仿生智慧膝關節市場
    • 澳洲仿生智慧膝關節市場
    • 其他亞太仿生智慧膝關節市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西仿生智慧膝關節市場
    • 南非仿生智慧膝關節市場
    • 沙烏地阿拉伯仿生智慧膝關節市場
    • 其他拉丁美洲/中東/非洲仿生智慧膝蓋市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位(2023年)

第8章 公司簡介

  • Stryker Corporation.
  • Zimmer Biomet Holdings, Inc.
  • Smith And Nephew Plc
  • Johnson And Johnson
  • B. Braun Melsungen AG
  • Medtronic
  • Ossur
  • Wright Medical Group NV
  • Exactech, Inc.
  • ConforMIS, Inc.
簡介目錄
Product Code: A323975

Bionic Smart Knee Market

The bionic smart knee market was valued at $1.3 billion in 2023 and is projected to reach $2.8 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

A bionic smart knee is a unique prosthetic device utilized for knee replacement. The device is equipped with sensors, microprocessors, and Bluetooth technology, which facilitate the replacement procedure. This smart knee imitates the natural functions of a human knee, along with enhancing comfort and mobility. The primary features of bionic smart knee include its dynamic adjustment capabilities and remarkable gait analysis. Moreover, the device's connectivity features enable its integration with external devices or mobile apps, allowing users to monitor their performance and customize the settings or performance.

Advancements in technology and material sciences are driving the growth of the bionic smart knee market as these upgraded devices offer refined functionality and experience to the users. In addition, rise in the prevalence of mobility issues and knee injuries, along with surge in awareness regarding the availability of advanced therapeutics is boosting the adoption of bionic smart knee. An emerging trend in the bionic smart knee market is the neuroprosthetic regulation of the device. Control of the smart knee through neural abilities is anticipated to amplify the imitation of natural human gait by the device. To facilitate neural control, the agonist and antagonist muscle pairs critical for knee movement need to be surgically connected to mimic the natural dynamics.

However, the availability of prosthetic devices and the facility to undergo a successful replacement are majorly restricted to developed regions, which hampers the market growth. In addition, the high cost of smart knee administration, maintenance, and insurance coverage prevents budget-sensitive patients from undergoing replacement, which limits the widespread expansion of the market. According to an article by the U.S. News & World Report-an American news magazine-on an average, robotic smart knee replacements cost around $2,400 higher than the conventional replacement surgeries. On the contrary, the market is poised for lucrative opportunities due to the advent of remote health. Bionic smart knee enables remote checkups and post-operative monitoring, eliminating the hassle of multiple hospital visits after surgery.

Segment Review

The bionic smart knee market is segmented into material, end user, and region. On the basis of material, the market is bifurcated into titanium and graphite. As per end user, it is divided into hospitals, orthopedic clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of material, the titanium segment dominates the bionic smart knee market.

As per end user, hospitals are the leading segment in the market.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global bionic smart knee market include Stryker Corporation., Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Johnson & Johnson, B. Braun Melsungen AG, Medtronic, Ossur, Wright Medical Group N.V., Exactech, Inc., and ConforMIS, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles

Key Market Segments

By Material

  • Titanium
  • Graphite

By End User

  • Hospitals
  • Orthopedic Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Stryker Corporation.
    • Zimmer Biomet Holdings, Inc.
    • Smith & Nephew plc
    • Johnson & Johnson
    • B. Braun Melsungen AG
    • Medtronic
    • Ossur
    • Wright Medical Group N.V.
    • Exactech, Inc.
    • ConforMIS, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIONIC SMART KNEE MARKET, BY MATERIAL

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Material
  • 4.2. Titanium
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Graphite
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: BIONIC SMART KNEE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Orthopedic Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: BIONIC SMART KNEE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Material
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Bionic Smart Knee Market
      • 6.2.5.1. Market Size and Forecast, By Material
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Bionic Smart Knee Market
      • 6.2.6.1. Market Size and Forecast, By Material
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Bionic Smart Knee Market
      • 6.2.7.1. Market Size and Forecast, By Material
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Material
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Bionic Smart Knee Market
      • 6.3.5.1. Market Size and Forecast, By Material
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Bionic Smart Knee Market
      • 6.3.6.1. Market Size and Forecast, By Material
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Bionic Smart Knee Market
      • 6.3.7.1. Market Size and Forecast, By Material
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Bionic Smart Knee Market
      • 6.3.8.1. Market Size and Forecast, By Material
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Bionic Smart Knee Market
      • 6.3.9.1. Market Size and Forecast, By Material
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Bionic Smart Knee Market
      • 6.3.10.1. Market Size and Forecast, By Material
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Material
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Bionic Smart Knee Market
      • 6.4.5.1. Market Size and Forecast, By Material
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Bionic Smart Knee Market
      • 6.4.6.1. Market Size and Forecast, By Material
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Bionic Smart Knee Market
      • 6.4.7.1. Market Size and Forecast, By Material
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Bionic Smart Knee Market
      • 6.4.8.1. Market Size and Forecast, By Material
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Bionic Smart Knee Market
      • 6.4.9.1. Market Size and Forecast, By Material
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Bionic Smart Knee Market
      • 6.4.10.1. Market Size and Forecast, By Material
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Material
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Bionic Smart Knee Market
      • 6.5.5.1. Market Size and Forecast, By Material
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Bionic Smart Knee Market
      • 6.5.6.1. Market Size and Forecast, By Material
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Bionic Smart Knee Market
      • 6.5.7.1. Market Size and Forecast, By Material
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Bionic Smart Knee Market
      • 6.5.8.1. Market Size and Forecast, By Material
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Stryker Corporation.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Zimmer Biomet Holdings, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Smith And Nephew Plc
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Johnson And Johnson
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. B. Braun Melsungen AG
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Ossur
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Wright Medical Group N.V.
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Exactech, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. ConforMIS, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments